OpenLegislation

Regulation 217C Amendment of regulation 307 (corrective statement)F1I1

In regulation 307—

(a)

in paragraph (1)(a), after “subject of the notice” insert—

“in—

(i)

Great Britain;

(ii)

Northern Ireland; or

(iii)

both Great Britain and Northern Ireland”;

(b)

in paragraph (1)(b), after “that advertisement” insert—

“in—

(i)

Great Britain;

(ii)

Northern Ireland; or

(iii)

both Great Britain and Northern Ireland”;

(c)

in paragraph (2)(a), for “, either in full or in part; and” substitute—

“in respect of—

(i)

Great Britain;

(ii)

Northern Ireland; or

(iii)

both Great Britain and Northern Ireland,

either in full or in part; and”.

Annotations

Textual amendments

F1

Regs. 217A-217D inserted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 177

Commencement

I1

Reg. 217C in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1